Research on type 2 diabetes mellitus (T2DM) drugs has revealed their potential in alleviating symptoms within Alzheimer’s disease patients, according to a report by GBI Research.
8 December 2016
1 December 2016
The seasonal influenza vaccines market is largely dominated by big pharmaceutical companies and expected to witness the entry of smaller companies, according to a report by GlobalData.
24 November 2016
The psoriatic arthritis market is projected to grow from $4.53bn in 2015 to approximately $12.6bn by 2025 in the seven major markets (7MM) of the US, France, Germany, Italy, Spain,...
17 November 2016
The market for synthetic cannabinoid products is growing despite legal restrictions, says a white paper from GBI Research.
10 November 2016
Positive results from a Phase III study on Alkermes’ ALKS-5461 shows promise towards the development of a new treatment for major depressive disorder (MDD), according to a report by GlobalData.
27 October 2016
Drug sales for major depressive disorders (MDD) in the US are expected to grow at a compound annual growth rate (CAGR) of 6.6% to reach $4.6bn by 2025, compared to...